Botanix Pharmaceuticals Ltd
ASX:BOT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Botanix Pharmaceuticals Ltd
ASX:BOT
|
AU |
|
Dali Foods Group Co Ltd
F:05M
|
CN |
|
V
|
VF Corp
DUS:VFP
|
US |
|
C
|
ConnectWave Co Ltd
KOSDAQ:119860
|
KR |
|
Hawaiian Electric Industries Inc
NYSE:HE
|
US |
|
Showcase Inc
TSE:3909
|
JP |
|
Cullinan Oncology Inc
NASDAQ:CGEM
|
US |
|
B
|
Biotest AG
OTC:BIESF
|
DE |
|
B
|
Biotest AG
F:BIO
|
DE |
|
N
|
NU Skin Enterprises Inc
F:NUS
|
US |
|
BBMG Corp
F:9BM
|
CN |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BOT's stock price target?
Not Available
BOT does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Botanix Pharmaceuticals Ltd?
Projected CAGR
195%
The compound annual growth rate for Revenue over the next 3 years is 195%.
What is the Gross Profit forecast for Botanix Pharmaceuticals Ltd?
Projected CAGR
292%
The compound annual growth rate for Gross Profit over the next 3 years is 292%.